CalciMedica, Inc.
CalciMedica, Inc. (CALC) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
calc · stock forecast · 3 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 3 Wall Street analysts in the past 3 months
Buy
3 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$392
Consensus
$266
+27666.2% upside
Low
$14.00
Median: $392 · Last Close: $0.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.01 | ↑ 5.00% |
1-day model range: $0.99–$1.02. Peak: $1.02 (+5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CALC · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-05 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-01-29 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-10 | Oppenheimer | Maintains | Outperform→Outperform |
| 2024-07-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on CalciMedica, Inc. (CALC) stock. Of the recent 18 rating actions, 0 were upgrades and 1 were downgrades. 3 analysts currently cover CALC.
Analyst Recommendation Trends
CALC analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2M
↓ 30.5% YoY
Revenue Next Year
$7M
↑ 174.0% YoY
EPS This Year
$-0.63
EPS Next Year
$-1.96
↑ 212.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast CALC EPS of $-0.63 for the current fiscal year, based on estimates from 2 analysts. The CALC revenue forecast is $2M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CALC stock forecast is supported by two independent data sources: analyst consensus ratings from 3 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CALC price target is $266.00 (+27666.2% upside), with an analyst consensus of Buy.
The CALC short-term stock prediction for tomorrow is $1.01 (+5.00%).
CalciMedica, Inc. trades on NASDAQ under the ticker CALC. The CALC stock outlook for 2027 is broadly positive, supported by a Buy consensus among 67% of covering analysts.
Frequently asked questions
CALC forecast · 8 questionsAccording to 3 Wall Street analysts, the average 12-month CALC price target is $266.00, with a high forecast of $392.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +27666.2% potential upside from the current price of $0.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.